Buchumschlag

A real world comparison of sulfonylurea and insulin vs. incretin-based treatments in patients not controlled on prior metformin monotherapy

Metformin is the first line drug for patients diagnosed with type-2 diabetes; however, the impact of different treatment escalation strategies after metformin failure has thus far not been investigated in a real world situation. The registry described herein goes some way to clarifying treatment out...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Gitt, Anselm Kai (VerfasserIn) , Bramlage, Peter (VerfasserIn) , Schneider, Steffen (VerfasserIn) , Tschöpe, Diethelm (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 03 February 2015
In: Cardiovascular diabetology
Year: 2015, Jahrgang: 14, Pages: 1-8
ISSN:1475-2840
DOI:10.1186/s12933-015-0172-9
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1186/s12933-015-0172-9
Volltext
Verfasserangaben:Anselm K. Gitt, Peter Bramlage, Steffen Schneider and Diethelm Tschöpe
Beschreibung
Zusammenfassung:Metformin is the first line drug for patients diagnosed with type-2 diabetes; however, the impact of different treatment escalation strategies after metformin failure has thus far not been investigated in a real world situation. The registry described herein goes some way to clarifying treatment outcomes in such patients.
Beschreibung:Gesehen am 11.08.2021
Beschreibung:Online Resource
ISSN:1475-2840
DOI:10.1186/s12933-015-0172-9

Ähnliche Einträge